Literature DB >> 26622895

Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines.

Nannan Lv1, Yun Gao2, Haixia Guan1, Dan Wu1, Shuangning Ding1, Weiping Teng1, Zhongyan Shan1.   

Abstract

Inflammatory mediators, tumor necrosis factor (TNF)-α and interferon (IFN)-γ, promote adverse outcomes in numerous types of cancer; however, their role in papillary thyroid cancer (PTC) remains unclear. The aim of the present study was to investigate the influence of TNF-α and IFN-γ on the migration, invasion and epithelial-mesenchymal transition (EMT) of the three PTC cell lines, TPC-1, BCPAP and K1. The effect of TNF-α and IFN-γ on cell migration and invasion was assessed by wound-healing and Transwell assays. In addition, the mRNA and protein expression levels of the EMT makers, E-cadherin, N-cadherin and vimentin, were analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunoblot analysis. The wound-healing and Transwell experiments revealed that TNF-α and IFN-γ increased the migratory and invasive behavior of PTC cells (P<0.05). RT-qPCR revealed that TNF-α and IFN-γ downregulated E-cadherin mRNA, while they upregulated N-cadherin and vimentin mRNA expression levels. These results were further confirmed by the immunoblot analysis. The results of the present study suggest that TNF-α and IFN-γ induce EMT and malignant progression in human PTC cells.

Entities:  

Keywords:  epithelial-mesenchymal transition; inflammation; invasion; migration; papillary thyroid cancer

Year:  2015        PMID: 26622895      PMCID: PMC4580000          DOI: 10.3892/ol.2015.3518

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells.

Authors:  Luca Ulianich; Corrado Garbi; Antonella Sonia Treglia; Dario Punzi; Claudia Miele; Gregory Alexander Raciti; Francesco Beguinot; Eduardo Consiglio; Bruno Di Jeso
Journal:  J Cell Sci       Date:  2008-01-22       Impact factor: 5.285

Review 2.  E-cadherin upregulation as a therapeutic goal in cancer treatment.

Authors:  E W Howard; K D Camm; Y C Wong; X H Wang
Journal:  Mini Rev Med Chem       Date:  2008-05       Impact factor: 3.862

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  [Trend of incidence and mortality on thyroid cancer in China during 2003 - 2007].

Authors:  Yu-Qin Liu; Shu-Quan Zhang; Wan-Qing Chen; Li-Li Chen; Si-Wei Zhang; Xiao-Dong Zhang; Rong-Shou Zheng
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-10

5.  Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways.

Authors:  Lee A Borthwick; Aaron Gardner; Anthony De Soyza; Derek A Mann; Andrew J Fisher
Journal:  Cancer Microenviron       Date:  2011-07-27

6.  Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.

Authors:  Zhiyan Liu; Kennichi Kakudo; Yanhua Bai; Yaqiong Li; Takashi Ozaki; Akira Miyauchi; Emiko Taniguchi; Ichiro Mori
Journal:  J Clin Pathol       Date:  2011-02-04       Impact factor: 3.411

7.  Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-10-01

8.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Authors:  Vasily Vasko; Allan V Espinosa; William Scouten; Huiling He; Herbert Auer; Sandya Liyanarachchi; Alexander Larin; Victoria Savchenko; Gary L Francis; Albert de la Chapelle; Motoyasu Saji; Matthew D Ringel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

9.  Expression of classical cadherins in thyroid development: maintenance of an epithelial phenotype throughout organogenesis.

Authors:  H Fagman; M Grände; J Edsbagge; H Semb; M Nilsson
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

10.  Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway.

Authors:  Valentina Sancisi; Greta Gandolfi; Moira Ragazzi; Davide Nicoli; Ione Tamagnini; Simonetta Piana; Alessia Ciarrocchi
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more
  20 in total

Review 1.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

Review 2.  Interplay between inflammatory tumor microenvironment and cancer stem cells.

Authors:  Shijian Zhang; Xi Yang; Lei Wang; Chenping Zhang
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

Review 3.  EMT and inflammation: inseparable actors of cancer progression.

Authors:  Meggy Suarez-Carmona; Julien Lesage; Didier Cataldo; Christine Gilles
Journal:  Mol Oncol       Date:  2017-06-26       Impact factor: 6.603

4.  3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition.

Authors:  Haihua Xie; Naishun Liao; Fenghua Lan; Zhixiong Cai; Xiaolong Liu; Jingfeng Liu
Journal:  Int J Mol Med       Date:  2017-12-20       Impact factor: 4.101

Review 5.  Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma.

Authors:  Long Yan; Feng Xu; Chao-Liu Dai
Journal:  J Exp Clin Cancer Res       Date:  2018-08-29

6.  Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.

Authors:  Shikha Saini; Lakshmi Sripada; Kiara Tulla; Prabhakaran Kumar; Fei Yue; Nicholas Kunda; Ajay V Maker; Bellur S Prabhakar
Journal:  Cell Death Dis       Date:  2019-02-13       Impact factor: 8.469

Review 7.  The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.

Authors:  Elisabetta Romeo; Carmelo Antonio Caserta; Cristiano Rumio; Fabrizio Marcucci
Journal:  Cells       Date:  2019-05-15       Impact factor: 6.600

8.  The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification.

Authors:  Jiaoyu Yi; Mengran Tian; Linfei Hu; Ning Kang; Weike Ma; Jingtai Zhi; Xiangqian Zheng; Xianhui Ruan; Ming Gao
Journal:  Ann Transl Med       Date:  2021-05

9.  Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy.

Authors:  Xiao-Li Chen; Yu-Jing Bai; Qin-Rui Hu; Shan-Shan Li; Lv-Zhen Huang; Xiao-Xin Li
Journal:  Mediators Inflamm       Date:  2016-06-09       Impact factor: 4.711

Review 10.  Interferon gamma in cancer immunotherapy.

Authors:  Ling Ni; Jian Lu
Journal:  Cancer Med       Date:  2018-07-23       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.